Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 24, 2005
Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group
A Jatoi, B R Murphy, N R Foster, et al.
Cancer
|
October 24, 2000
A North Central Cancer Treatment Group Phase II trial of 9-aminocamptothecin in previously untreated patients with measurable metastatic colorectal carcinoma
H C Pitot, J A Knost, M R Mahoney, et al.
JAMA
|
November 19, 1982
A multiple-dose phase I trial of recombinant leukocyte A interferon in cancer patients
S A Sherwin, J A Knost, S Fein, et al.
Investigational New Drugs
|
June 9, 1999
Phase II trial of 150-minute weekly infusion of gemcitabine in advanced colorectal cancer: minimal activity in colorectal cancer
S Mani, J W Kugler, J A Knost, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2000
Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial
S K Quella, C L Loprinzi, D L Barton, et al.
Hybridoma
|
January 1, 1984
Monoclonal antibodies to human colorectal tumor-associated antigens: improved elicitation and subclass restriction
A C Morgan, C S Woodhouse, J A Knost, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 16, 2000
A randomized phase II trial of two schedules of topotecan for the treatment of advanced stage non-small cell lung cancer
J J Weitz, R F Marschke, J A Sloan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1997
Phase II trial of irinotecan in patients with metastatic colorectal carcinoma
H C Pitot, D B Wender, M J O'Connell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 1997
Prospectively randomized North Central Cancer Treatment Group trial of intensive-course fluorouracil combined with the l-isomer of intravenous leucovorin, oral leucovorin, or intravenous leucovorin for the treatment of advanced colorectal cancer
R M Goldberg, A K Hatfield, M Kahn, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 24, 2005
Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group
A Jatoi, B R Murphy, N R Foster, et al.
Cancer
|
October 24, 2000
A North Central Cancer Treatment Group Phase II trial of 9-aminocamptothecin in previously untreated patients with measurable metastatic colorectal carcinoma
H C Pitot, J A Knost, M R Mahoney, et al.
JAMA
|
November 19, 1982
A multiple-dose phase I trial of recombinant leukocyte A interferon in cancer patients
S A Sherwin, J A Knost, S Fein, et al.
Investigational New Drugs
|
June 9, 1999
Phase II trial of 150-minute weekly infusion of gemcitabine in advanced colorectal cancer: minimal activity in colorectal cancer
S Mani, J W Kugler, J A Knost, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2000
Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial
S K Quella, C L Loprinzi, D L Barton, et al.
Hybridoma
|
January 1, 1984
Monoclonal antibodies to human colorectal tumor-associated antigens: improved elicitation and subclass restriction
A C Morgan, C S Woodhouse, J A Knost, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 16, 2000
A randomized phase II trial of two schedules of topotecan for the treatment of advanced stage non-small cell lung cancer
J J Weitz, R F Marschke, J A Sloan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1997
Phase II trial of irinotecan in patients with metastatic colorectal carcinoma
H C Pitot, D B Wender, M J O'Connell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 1997
Prospectively randomized North Central Cancer Treatment Group trial of intensive-course fluorouracil combined with the l-isomer of intravenous leucovorin, oral leucovorin, or intravenous leucovorin for the treatment of advanced colorectal cancer
R M Goldberg, A K Hatfield, M Kahn, et al.
Page
of 2